The clinical trial of Uloric found no difference in heart risks between patients taking Uloric and those taking the currently available drug allopurinol.
FDA panel voted 12-0 to recommend approval of Uloric for chronic gout.
Gout is caused by a build-up of uric acid in the blood. Uloric reduces levels of uric acid.
저작권자 © 헬스코리아뉴스 무단전재 및 재배포 금지